Skip to content

Conversation

@haleygreenwell
Copy link
Contributor

Added the CReATe dataset, DAU, S1

Just review, don't merge!
WAIT - DAU is not yet ready.

@kevin-benton kevin-benton added the blocked This task is blocked pending action elsewhere label Oct 28, 2025

**DAU**: CReATe | **Tissue Type**: PBMC germline DNA | **Sequencing Type**: WGS | **Samples**: 705

The Phenotype-Genotype-Biomarker (PGB, or PGB1) study (NCT02327845) of the Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium was a natural history and biomarker study of patients with amyotrophic lateral sclerosis (ALS) or a related disorder, including but not limited to ALS-frontotemporal dementia (ALS-FTD), progressive muscular atrophy (PMA), primary lateral sclerosis (PLS), hereditary spastic paraplegia (HSP), and multisystem proteinopathy (MSP). In addition to patients enrolled in the PGB1 Cohort (primary participants), the study also enrolled family members for limited data collection (secondary participants). This dataset includes WGS data from N=705 in PGB1, including N=472 ALS/ALS-FTD, N=20 PMA, N=47 PLS, N=162 HSP, and N=4 with other related disorders.
Copy link
Member

Choose a reason for hiding this comment

The reason will be displayed to describe this comment to others. Learn more.

We should add a sentence at the end saying "the findings of the project were published in ..."

Copy link
Contributor Author

Choose a reason for hiding this comment

The reason will be displayed to describe this comment to others. Learn more.

Sounds good - but for now, the publication is in progress/hasn't yet been released.

Copy link
Contributor Author

Choose a reason for hiding this comment

The reason will be displayed to describe this comment to others. Learn more.

Copy link
Member

@claymcleod claymcleod left a comment

Choose a reason for hiding this comment

The reason will be displayed to describe this comment to others. Learn more.

Just one comment here.

Copy link
Contributor

@kevin-benton kevin-benton left a comment

Choose a reason for hiding this comment

The reason will be displayed to describe this comment to others. Learn more.

One small nit. The code follows a 1 sentence per line paradigm. I'd like to see that consistency throughout.


**DAU**: CReATe | **Tissue Type**: PBMC germline DNA | **Sequencing Type**: WGS | **Samples**: 705

The Phenotype-Genotype-Biomarker (PGB, or PGB1) study (NCT02327845) of the Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium was a natural history and biomarker study of patients with amyotrophic lateral sclerosis (ALS) or a related disorder, including but not limited to ALS-frontotemporal dementia (ALS-FTD), progressive muscular atrophy (PMA), primary lateral sclerosis (PLS), hereditary spastic paraplegia (HSP), and multisystem proteinopathy (MSP). In addition to patients enrolled in the PGB1 Cohort (primary participants), the study also enrolled family members for limited data collection (secondary participants). This dataset includes WGS data from N=705 in PGB1, including N=472 ALS/ALS-FTD, N=20 PMA, N=47 PLS, N=162 HSP, and N=4 with other related disorders. The findings of the project were published in [Translational Neurodegeneration](https://translationalneurodegeneration.biomedcentral.com/articles/10.1186/s40035-025-00516-2).
Copy link
Contributor

Choose a reason for hiding this comment

The reason will be displayed to describe this comment to others. Learn more.

nit: The code is following the 1 sentence per line paradigm.

Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment

Labels

blocked This task is blocked pending action elsewhere

Projects

None yet

Development

Successfully merging this pull request may close these issues.

5 participants